在肝细胞癌中,KRT80通过表皮细胞-介质细胞过渡和PI3K/AKT通路发挥致癌作用
Ruheng Hua1,2, Xiyue Yan3, Jun He1
1Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
IUBMB life
|November 21, 2024
概括
氨酸80 (KRT80) 在肝细胞癌 (HCC) 中被上调,促进癌症生长和转移. 针对KRT80可能为晚期HCC患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 肝细胞癌 (HCC) 是一种流行癌症,具有侵略性生长和早期转移.
- 对于晚期HCC的有效治疗仍然至关重要.
- 了解推动HCC进展的分子机制至关重要.
研究的目的:
- 研究KRT80在肝细胞癌中的作用.
- 确定KRT80表达是否与患者预后相关.
- 阐明KRT80在HCC中的功能和机制影响.
主要方法:
- 在HCC样本中分析KRT80表达.
- KRT80水平与患者生存数据的相关性.
- 在体外和体内功能增加和丧失的研究.
- 调查KRT80对表皮层-介质酶过渡 (EMT) 和PI3K/AKT信号通路的影响.
主要成果:
- 发现KRT80在HCC组织中受到上调.
- 较高的KRT80表达与HCC患者的整体存活率较差有关.
- KRT80增强了HCC细胞的增殖,迁移,入侵和血管生成.
- 沉默KRT80抑制了这些致癌性质在体外和体内.
- KRT80影响EMT,并调节PI3K/AKT通路.
结论:
- 在肝细胞癌中,KRT80作为瘤基因起作用.
- KRT80是HCC的潜在独立预后风险因素.
- 准KRT80为HCC预防和治疗提供了一个有希望的途径.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
Receptor Tyrosine Kinases
12.3K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
12.3K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


